Loading...
Real-world experience with obeticholic acid in patients with primary biliary cholangitis
BACKGROUND & AIMS: Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. METHODS: Pa...
Saved in:
| Published in: | JHEP Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930359/ https://ncbi.nlm.nih.gov/pubmed/33681748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|